Track: Interventional Cardiology and Structural Heart Disease
Interventional cardiology continues to redefine what is achievable without open surgery. TAVI now accounts for the majority of aortic valve replacements across all surgical risk categories, and transcatheter therapies are rapidly expanding to mitral and tricuspid valve disease. The Interventional Cardiology & Structural Heart Disease session examines 5-year TAVI outcomes in low-risk patients, the COAPT-established evidence base for transcatheter mitral edge-to-edge repair (TEER), emerging transcatheter tricuspid therapies, left atrial appendage occlusion, and physiology-guided PCI using iFR/FFR with intravascular imaging - including chronic total occlusion PCI and complex left main disease management.
Key Discussion Areas:
- TAVI in low-risk patients: 5-year outcomes and lifetime valve management
- Transcatheter mitral edge-to-edge repair (TEER): COAPT and real-world outcomes
- Emerging transcatheter tricuspid valve therapies
- Physiology-guided PCI: iFR, FFR, and non-hyperaemic pressure ratios
- Intravascular imaging (OCT/IVUS) in complex coronary intervention
- Chronic total occlusion (CTO) PCI: contemporary techniques and outcomes
- Transcatheter aortic valve-in-valve procedures
- Left atrial appendage occlusion: updated evidence and device selection
Why Attend This Session?
Interventional cardiologists, cardiac surgeons, structural heart disease teams, and cath lab professionals will gain comprehensive updates on trial evidence, device selection algorithms, and operator technique across coronary and structural heart interventions, bridging innovation with real-world implementation.
Related Topics
- Valvular Heart Disease
- Cardiac Imaging & Advanced Diagnostics
- Heart Failure & Cardiomyopathies
- Cardiovascular Surgery
- AI in Cardiology
Frequently Asked Questions
1.What is the importance of interventional cardiology and structural heart disease in cardiovascular medicine?
Interventional Cardiology and Structural Heart Disease plays a significant role in improving diagnosis, treatment strategies, patient outcomes, and clinical decision-making in modern cardiology.
2.What are the latest trends in interventional cardiology and structural heart disease?
Recent trends include precision medicine, AI-assisted diagnostics, minimally invasive therapies, digital healthcare technologies, and personalized patient management.
Scientific Highlights
- Preventive Cardiology and Cardiovascular Risk Reduction
- Heart Failure and Advanced Cardiac Therapies
- Interventional Cardiology and Structural Heart Disease
- Cardiac Electrophysiology and Arrhythmia Management
- Acute Coronary Syndromes
- Cardiovascular Imaging and Multimodality Diagnostics
- Cardiomyopathies: Genetics, Phenotyping, and Treatment
- Cardio Oncology
- Cardiometabolic Disease, Lipidology, and Atherosclerosis
- Hypertension and Renal Cardiovascular Interactions
- Digital Health, AI, and the Future of Cardiology
- Pediatric and Congenital Cardiology
- Vascular Medicine and Aortic Diseases
- Women's Cardiovascular Health and Sports Cardiology
- Precision Medicine, Genomics, and Regenerative Cardiology
- Cardiovascular and Cardiothoracic Surgery
- Cardiovascular Case Studies and Clinical Insights
- Emergency and Critical Cardiac Care
Organization Location
1309 Coffeen Avenue, STE 1200, Sheridan, Wyoming 82801, USA
Mail us at
Conference Enquiry - Kristina Pierce
kristinapierce@scientexconferences.com
General Enquiry
contact@scientexconferences.com
Registration Enquiry
finance@scientexconferences.com
cardiacsurgery@scientexevents.org
Our Social Presence
Call us at
USA : (+1) 272 374 1068